Home / Mirtazapine

‘Major’ depression medication recalled for mislabeled strength

The FDA reports Aurobindo Pharma USA, Inc. is voluntarily recalling Mirtazapine, a medication used for treatment of “major depressive disorder,” due to a label error of the declared strength of a certain lot. The affected lot number for both Mirtazapine Tablets 7.5 mg and Mirtazapine Tablets 15 mg are 03119002A3 Exp 03/2022. The product can […]